
Avotres Inc. Founder and CSO, Dr. Hong Jiang Presented at the 7th Treg-Directed Therapies Summit
BOSTON, MA, UNITED STATES, March 26, 2025 /EINPresswire.com/ -- Avotres proudly announces the successful presentation, titled as “Analyzing the Q/E CD8+ Treg Pathway to Unlock Effective Clinical Applications: Q/E CD8+Treg Pathway Directed …